The British Menopause Society (BMS) board of trustees is pleased to announce that Mr Paul Simpson has taken up his position as Chair. He assumed office at the end of the BMS Annual General Meeting (AGM), which took place online on Wednesday 23 September 2026. From left to right: Professor Janice Rymer, Mr [...]
A large nationwide case-control study from Denmark, published this month, examines associations between current use of menopausal hormone therapy (MHT) and risk of venous thromboembolism (VTE), ischaemic stroke, and myocardial infarction (MI).MHT remains an effective and well-established treatment for menopausal symptoms, with recognised benefits for quality of life and bone health. As with all treatments, [...]
Dr Heather Currie and Kathy Abernethy, BMS Trustees, and Emily Josif, BMS Communications Manager, were invited to attend the Menopause Society of Ireland (MSI) Conference on 12 September 2026. The event was dedicated this year to a single, clear theme: debunking menopause myths that continue to affect menopause care and post reproductive health. Misinformation [...]
The British Menopause Society (BMS) is pleased to announce the launch of a new Instagram page for Women’s Health Concern (WHC), the patient voice of the BMS.There is a growing concern about the volume of unregulated and, in some cases, inaccurate menopause-related information circulating on social media and other online platforms. This Instagram page has [...]
The board of trustees of the British Menopause Society (BMS) is pleased to announce the appointment of Kathy Abernethy as Director of Clinical Practice, a new role within the Society. Kathy Abernethy is a founding member of the British Menopause Society, having joined its first council in 1990. She has since served as Chair [...]
Premature ovarian insufficiency (POI) and early menopause (EM) affect an estimated 4% and 12% of women respectively, with significant adverse health and psychological impacts. In 2024, the International Menopause Society (IMS), in partnership with the European Society for Human Reproduction and Embryology (ESHRE), the American Society for Reproductive Medicine (ASRM) and the Monash Centre [...]
Healthcare professionals who see menopausal women with vulvo-vaginal atrophy (VVA), as part of genitourinary syndrome of menopause (GSM), are invited to take part in a new University of Melbourne survey exploring how this condition is diagnosed, discussed and treated in practice. The survey is part of a qualitative research project documenting the perspectives of [...]
Extended MHRA licence for elinzanetant in breast cancer patients The Medicines and Healthcare products Regulatory Agency (MHRA) has extended the licence for elinzanetant, an NK1/NK3 receptor antagonist, for the treatment of moderate to severe vasomotor symptoms in women receiving adjuvant endocrine therapy for breast cancer. This is the first medicine specifically licensed for this [...]
New WHC Fact Sheet: Hormone blood tests in the menopause transition Women's Health Concern (WHC), the patient arm of the British Menopause Society (BMS), has published a new fact sheet examining the role of hormone blood tests in the menopause transition. The resource builds on the BMS Tool for Clinicians on the measurement of [...]
The British Menopause Society has published a new BMS Tool for Clinicians: Menopausal 'brain fog' or dementia? – a practical guide for clinicians. Cognitive symptoms such as memory lapses, difficulty concentrating, and mental fatigue, collectively known as 'brain fog', are frequently reported during perimenopause and menopause, causing patient distress and sometimes prompting concern about [...]
